PATENT CLAIM ANALYSIS

Application Number: 16061597
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "362000"]

Abstract:
Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Claim (Index 6):
The compound of  claim 1 , wherein:\n R is selected from:\n (a) hydrogen, \n (b) OR a , \n (c) C 3-6 cycloalkyl, optionally substituted with one to four substituents independently selected from:\n (i) C 1-6 alkyl, and \n (ii) CN, \n \n (d) phenyl, optionally substituted with one to four substituents independently selected from:\n (i) halogen, \n (ii) C 1-6 alkyl, and \n (iii) \u2014S(O) 2 \u2014NH\u2014R 4 , \n \n (e) a 4-, 5- or 6-membered heterocyclyl selected from azetidinyl, 1,2,5-thiadiazolidinyl, imidazolidinyl, oxazolidinyl, oxetanyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, tetrahydropyranyl, tetrahydro-2H-thiopyranyl, 4,5-dihydro-1H-1,2,4-triazolyl, dihydropyridazinyl, dihydropyridinyl, furanyl, imidazolyl, dihydro-oxadiazolyl, pyridinyl, thiazolyl, and triazolyl; each of which is optionally substituted with one to four substituents independently selected from:\n (i) halogen, \n (ii) C 1-6 alkyl, optionally substituted with one to three halogens, \n (iii) oxo, \n (iv) \u2014S(O) 2 \u2014NH\u2014R 4 , and \n (v) \u2014(C\u2550O)\u2014C 1-6 alkyl, \n \n (f) CN, \n (g) \u2014(C\u2550O)\u2014R a , \n (h) \u2014(C\u2550O)NH\u2014R a , \n (i) \u2014P(O)(OR a ) 2 , \n (j) \u2014P(O)(NHR a )(OR a ), \n (k) C 2-4 alkynyl, \n (m) \u2014NR x R y , wherein each of R x  and R y  is independently selected from:\n (i) hydrogen, \n (ii) C 1-6 alkyl, optionally substituted with a 4-, 5- or 6-membered heterocyclyl, \n (iii) C 3-6 cycloalkenyl, optionally substituted with one to four substituents independently selected from NH\u2014R a , oxo, and 4-, 5- or 6-membered heterocyclyl, \n (iv) C 2-4 alkenyl, optionally substituted with one to four substituents independently selected from NR 4  and NO 2 , \n (v) \u2014(C\u2550O)\u2014R a , \n (vi) \u2014(C\u2550O)\u2014C 3-6 cycloalkyl, \n (vii) \u2014(C\u2550O)\u2014NR 4 R a , \n (viii) aryl, \n (ix) heteroaryl, \n (x) \u2014(C\u2550NH)(NH 2 )\u2014CN, \n (xi) \u2014S(O) 2 \u2014R a , and \n (xii) \u2014S(O) 2 \u2014NH\u2014R a ;

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 2.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13780510', '11641284', '15632986', '13734263', '11430441']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8029243171183786
- 35 USC 102 Novelty (BERT): 0.5871390578937989
- Combined Prediction Score: 0.7813457911959206
- Mean Citation Score: 485.00033600000006
- Max Citation Score: 496.86115
- Similarity Product: 417.88632835733887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test